A detailed history of Dimensional Fund Advisors LP transactions in Innoviva, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 4,692,926 shares of INVA stock, worth $83.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,692,926
Previous 4,684,594 0.18%
Holding current value
$83.7 Million
Previous $76.8 Million 17.89%
% of portfolio
0.02%
Previous 0.02%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$16.33 - $20.04 $136,061 - $166,973
8,332 Added 0.18%
4,692,926 $90.6 Million
Q2 2024

Aug 09, 2024

BUY
$14.4 - $16.4 $1.03 Million - $1.17 Million
71,336 Added 1.55%
4,684,594 $76.8 Million
Q1 2024

May 10, 2024

BUY
$14.56 - $16.78 $1.4 Million - $1.62 Million
96,259 Added 2.13%
4,613,258 $70.3 Million
Q4 2023

Feb 07, 2024

BUY
$12.32 - $16.27 $816,754 - $1.08 Million
66,295 Added 1.49%
4,516,999 $72.5 Million
Q3 2023

Nov 09, 2023

BUY
$12.37 - $13.89 $3.33 Million - $3.74 Million
269,197 Added 6.44%
4,450,704 $57.8 Million
Q2 2023

Aug 09, 2023

BUY
$11.39 - $13.72 $4.55 Million - $5.48 Million
399,303 Added 10.56%
4,181,507 $53.2 Million
Q1 2023

May 12, 2023

BUY
$10.73 - $13.6 $6.17 Million - $7.82 Million
575,010 Added 17.93%
3,782,204 $42.5 Million
Q4 2022

Feb 09, 2023

BUY
$11.8 - $13.78 $3.2 Million - $3.74 Million
271,075 Added 9.23%
3,207,194 $42.5 Million
Q3 2022

Nov 10, 2022

BUY
$11.61 - $15.22 $2.76 Million - $3.62 Million
237,843 Added 8.81%
2,936,119 $34.1 Million
Q2 2022

Aug 12, 2022

BUY
$14.32 - $19.88 $2.26 Million - $3.14 Million
157,882 Added 6.21%
2,698,276 $39.8 Million
Q1 2022

May 13, 2022

BUY
$15.39 - $20.25 $108,530 - $142,803
7,052 Added 0.28%
2,540,394 $49.2 Million
Q4 2021

Feb 09, 2022

SELL
$15.91 - $18.72 $21,526 - $25,328
-1,353 Reduced 0.05%
2,533,342 $43.7 Million
Q3 2021

Nov 12, 2021

BUY
$13.06 - $17.24 $945,178 - $1.25 Million
72,372 Added 2.94%
2,534,695 $42.4 Million
Q2 2021

Aug 12, 2021

BUY
$11.45 - $13.96 $1.63 Million - $1.99 Million
142,265 Added 6.13%
2,462,323 $33 Million
Q1 2021

May 14, 2021

SELL
$11.06 - $12.87 $360,213 - $419,163
-32,569 Reduced 1.38%
2,320,058 $27.7 Million
Q4 2020

Feb 25, 2021

BUY
$9.33 - $12.48 $22 Million - $29.4 Million
2,352,627 New
2,352,627 $29.1 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.24B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.